Command Palette

Search for a command to run...

Clinical Trials · NCT03151005

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Xinqiao Hospital of Chongqing
Enrollment
70
Start date
Jul 2017
Locations
1 site, China
Primary endpoint
Assessment of Reproductive Functions
View Liraglutide compound reference